Articles On Adherium (ASX:ADR)

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

The ASX finished 0.67% higher, marking the best performance by the Australian bourse since early October. Almost all sectors finished higher with energy and tech – two sectors under siege in recent weeks – recording gains of 2.07% and 1.9%...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The ASX limped into the close on Friday, in a fairly tame finish to a roller-coaster week. Evergrande contagion fears and jitters ahead of the US Fed meeting sparked a sharp selloff on Monday. But a week (or three days) is a long time in ma...

The ASX 200 health stocks index (XHJ) is down by 0.82% at the time of writing, compared to the broader ASX 200 index which is down by 0.08% Respiratory tech specialist, Adherium (ASX:ADR), jumped 12% this morning after saying it was awarded...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

Highlights  ASX 200 ended the trading session on 10 September 2021 in the green zone. Amani Gold, Norwest and Adherium were the top three stocks that traded heavily on ASX. On Friday, 10 September 2021, ASX 200 ended the day’s trad...

The ASX regained some lost ground from yesterday’s bloodbath, but closed this week lower than what it began. The ASX 200 gained 0.5% to close at 7,407 points while the ASX Emerging Companies Index rose 2.45% to close at 2,469. Most sectors...

The Adherium Ltd (ASX: ADR) share price soared to dizzying heights today. This comes after the digital healthcare company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA). At the end of...

After treading water since the start of September, the ASX 200 took a dive in Thursday trade to finish 1.90% lower. Stocks lost ground at the opening bell and kept falling throughout the day, with steady falls across the board. Local stocks...

The ASX Health Care index (XHJ) was down by 0.11% this morning, compared with the broader ASX 200 index which fell by more than 1% at the time of writing. Medicinal cannabis company, Epsilon Healthcare (ASX:EPN), jumped by 20% out of the bl...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Respiratory eHealth company Adherium (ASX:ADR) has announced that it has received US FDA) 510(k) clearance to market its next-generation Hailie Sensor with physiological measures for monitoring asthma and COPD medication use....

The ASX 200 rose 0.07%, closing at 7,529 points while the ASX Emerging Companies Index climbed 1.21% to close at 2,461. Energy lost 1.68% and resources lost 1.09% but most other sectors gained with the best being tech which rose 1.15%.   TO...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The USA is the world’s largest healthcare market and therefore a dream for ASX health stocks to enter. This is no easy feat – needing to obtain the approval from the FDA, a regulator renowned as the world’s most sophisticated – but one that...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Respiratory eHealth company Adherium (ASX:ADR) has submitted to the US FDA seeking clearance of its updated Hailie sensor with physiological measures for monitoring Asthma and COPD medication use.

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

The ASX had a solid start to the week, gaining over 1 per cent and hitting a record high. The ASX 200 closed 1.3 per cent up at 7,172.8 which is a record closing high although not quite an all-time intra day high. The #ASX 200 rose by 92pt...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Healthcare f...

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

As the quarterlies continue to roll in across the afternoon, here are five prominent companies whose reports you may have missed.   Osteopore (ASX:OSX) The medical scaffold maker made revenues of $318,103 — a company record — and booked gro...

Summary NTL price of New Talisman Gold Mines hit a two-month high today, trading 33.3% higher at AU$0.004. VIP Gloves’ share price shot up by 42% to AU$0.071 in today’s session, posting a new YTD high of AU$0.078. Japara Healthcare’s...

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Leading healthcare investment firm BioScience Managers argues digital therapeutics will be the next big thing in healthcare – but Australia’s at risk of missing out. Hearing the words “digital therapeutics” (or DTx) might make you think of...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week “Another s...

Australian company Adherium (ASX:ADR), which is focused on respiratory eHealth, remote monitoring and data management solutions, has secured subscription commitments totalling $18 million.

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

The ASX finished in the red today dragged down by resources and energy. Materials and Energy stocks lost over 1 per cent each while Tech was the best sector gaining 0.70 per cent. Large caps fared worse than small caps with the ASX 200 losi...

The ASX had a positive day today gaining 0.8 per cent and all sectors finished in the green except resources and energy. Resources and Energy stocks fell 0.24 per cent and 0.55 per cent but the broader ASX 200 rose 0.87 per cent and all oth...

Source:New Africa ,Shutterstock Summary COVID-19 had a significant impact on the HeraMED’s and Adherium’s first half 2021 results. However, the two players made critical developments during the period. HeraMED plans to expand further...

The company develops, manufactures and supplies a broad range of connected medical devices for respiratory medications and its Hailie® solution is designed to help patients achieve better adherence and provide visibility to parents and care...

A quick wrap of the ASX’s key winners and losers on Monday, August 31. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 838 stocks rose, 662 declined and 5...

The sudden drop in spot gold prices and reintroduction of COVID-19 restrictions in New Zealand have hit the relevant ASX small caps this morning. After 100 days of being virus-free, four COVID-19 cases were detected in the country. New Zeal...

Australian company Adherium (ASX: ADR) has announced the appointment of Geoff Feakes as its chief technology officer (CTO).

Telehealth use has only continued to increase as COVID-19 wore on throughout May and June. Both listed and non-listed plays such as healthcare booking service HealthEngine saw demand rise exponentially as the pandemic broke out and this has...

A quick wrap of the ASX’s key winners and losers on Monday, July 13. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 715 stocks rose, 639 decl...

COVID-19 has forced many companies to adjust the way they operate and many companies think it will be lasting. National Australia Bank (NAB) conducted a survey asking businesses to rate the extent they believe changes in their organisation...

A quick wrap of the key winners and losers on Thursday, April 30. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. WINNERS CODE COMPANY PR...

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 61 were in positive territory over the last fortnight, 10 were flat and 66 saw their share prices fall. Code Name...

The announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders begin to pile up and the pre-open share price begins to surge. But while a nod from Australia’s drug and device regulator, the Therapeutic Go...